Chronic Ventricular Assist Device Support in Adult Congenital Heart Disease Patients: A Children's Hospital Perspective.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
pubmed:
30
10
2021
medline:
15
12
2021
entrez:
29
10
2021
Statut:
ppublish
Résumé
With improvement in early surgical outcomes in patients with complex congenital heart disease, most patients are now expected to survive to adulthood. As adult congenital heart disease (ACHD) patients age, they are at risk of heart failure, which has become the leading cause of mortality in ACHD. Some who develop advanced heart failure may not be candidates for transplant, and chronic ventricular assist device (VAD) therapy may be the only means of survival. There is limited experience with chronic VAD therapy in ACHD patients, and the outcomes are not well delineated. We describe our center's experience with chronic VAD therapy in ACHD patients receiving care exclusively within our children's hospital.
Identifiants
pubmed: 34711747
doi: 10.1097/MAT.0000000000001595
pii: 00002480-202112000-00016
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e216-e220Informations de copyright
Copyright © ASAIO 2021.
Déclaration de conflit d'intérêts
A.L. is a consultant for Abbott, Syncardia, Medtronic, Abiomed, and Berlin Heart Inc. D.L.S.M. is a consultant for Abbott, Berlin Heart, CorMatrix/Azyio, Medtronic, and SynCardia Systems. The other authors have no conflicts of interest to report.
Références
Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 56: 1149–1157, 2010.
Burchill LJ, Gao L, Kovacs AH, et al. Hospitalization trends and health resource use for adult congenital heart disease-related heart failure. J Am Heart Assoc. 7: e008775, 2018.
Burstein DS, Rossano JW, Griffis H, et al. Greater admissions, mortality and cost of heart failure in adults with congenital heart disease. Heart. 107: 807–813, 2021.
Agarwal A, Dudley CW, Nah G, Hayward R, Tseng ZH. Clinical outcomes during admissions for heart failure among adults with congenital heart disease. J Am Heart Assoc. 8: e012595, 2019.
Everitt MD, Donaldson AE, Stehlik J, et al. Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 30: 395–401, 2011.
Teuteberg JJ, Cleveland JC Jr, Cowger J, et al. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: the changing landscape of devices and indications. Ann Thorac Surg. 109: 649–660, 2020.
Cedars A, Vanderpluym C, Koehl D, Cantor R, Kutty S, Kirklin JK. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant. 37: 619–630, 2018.
Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS. Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices. J Heart Lung Transplant. 32: 1059–1064, 2013.
Morales D, ODonnell A. HeartMate 3™ Implant in Pediatric Patient With Dilated Cardiomyopathy. December 2019. doi:10.25373/ctsnet.11347892.
Villa CR, Alsaied T, Morales DLS. Ventricular assist device therapy and fontan: a story of supply and demand. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 23: 62–68, 2020.
Modica M, Ferratini M, Torri A, et al. Quality of life and emotional distress early after left ventricular assist device implant: a mixed-method study. Artif Organs. 39: 220–227, 2015.
Lorts A, Villa C, Riggs KW, Broderick J, Morales DLS. First use of heartmate 3 in a failing fontan circulation. Ann Thorac Surg. 106: e233–e234, 2018.
VanderPluym CJ, Cedars A, Eghtesady P, et al. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant. 37: 89–99, 2018.
Tunuguntla H, Conway J, Villa C, Rapoport A, Jeewa A. Destination-therapy ventricular assist device in children: “the future is now.” Can J Cardiol. 36: 216–222, 2020.
Lorts A, Smyth L, Gajarski RJ, et al. The Creation of a pediatric health care learning network: the ACTION quality improvement collaborative. ASAIO J. 66: 441–446, 2020.